Skip to main content

Dr Charlotte Elder

Charlotte Elder profile pic

Dr Charlotte Elder

Role: Consultant in Paediatric Endocrinology and Diabetes, Partner Governor - University of Sheffield
Email:
Telephone:
Profile

Charlotte Elder received her undergraduate medical degree from Imperial College, (University of London) UK in 1999 and, after initially training as a general practitioner, retrained in paediatrics and further specialised in paediatric endocrinology and diabetes. She moved from London to Sheffield in 2005 in pursuit of excellent paediatric endocrinology training combined with affordable housing and fabulous local countryside.

Dr Elder is a Consultant in Paediatric Endocrinology and Diabetes at Sheffield Children’s Hospital and a Senior Clinical Lecturer in the Department of Oncology and Metabolism at the University of Sheffield. She took up the post of Partner Governor in 2018. Her clinical commitments include clinics n general endocrinology, Paediatric and Adolescent Gynaecology, paediatric diabetes and Young Person’s diabetes. Her main research has focused on the development of a novel drug for the diagnosis of adrenal insufficiency (failure of the adrenal glands to produce adequate levels of the stress hormone cortisol). Her clinical interests are adrenal insufficiency and paediatric and adolescent gynaecology.

Research Interests

Charlotte Elder’s main research has been in the development of a non-invasive Short Synacthen Test for adrenal insufficiency, with a novel formulation of Synacthen for nasal administration and the measurement of the glucocorticoid response in saliva samples. She has led a team over five pharmacokinetic studies in adults and children. There is a patent application filed for the novel formulation and both commercial and research arms to the current workstream.

Recent Publications

  • Elder CJ, Langley J, Stanton A, De Silva S, Akbarian-Tefaghi L, Wales JHK, Wright NP. A Simulation Study Assessing the Accuracy and Reliability of Orchidometer Estimation of Testicular Volume. Clin Endo (Oxf) 2019. (DOI 10.1111/cen.13923)
  • Elder CJ, Harrison RH, Cross AS, Vilela R, Keevil BG, Wright NP, Ross RJ. Use of salivary cortisol and cortisone in the high- and low-dose Synacthen test. Clin Endocrinol (Oxf) 2018,88:772-778 (DOI: 10.1111/cen.13509) (selected for monthly commentary)
  • Cross AS, Kemp EH, White A, Walker L, Meredith S, Sachdev P, Krone NP, Ross RJ, Wright NP, Elder CJ. International survey on high- and low-dose synacthen test and assessment of accuracy in preparing low-dose synacthen. Clin Endocrinol (Oxf) 2018;88:744-751 (selected as Editor’s choice)
  • Cockill TG, Hewitt A, Heafey C, Wright NP, Elder CJ. The use of a radiolucent template to improve bone age X-ray quality (BASIC study). J Ped Endocrinol Metab2017; 30(12): 1277-80
  • Elder CJ, Dimitri PJ. Diabetes Insipidus and the use of desmopressin in hospitalised children. Arch Dis Child Educ Pract Ed 2017; 102: 100-104
  • King DA, West NS, Elder CJ. Integrating teaching into everyday clinical practice. Arch Dis Child Educ Pract Ed 2017; 102: 94-99 (Commissioned, externally peer reviewed).
  • Elder CJ, Dimitri PJ. Hydrocortisone for adrenal insufficiency. Arch Dis Child Educ Pract Ed 2015;100 272-276
  • Elder CJ, Wright NP. Height estimation using long bone segment length is unlikely to play a role in the routine measurement of healthy pre-school children. Developmental Medicine and Child Neurology 2014. Invited commentary. Doi:10.1111dmcn.12536.
  • Elder CJ, Bishop NJ. Rickets Seminar. Lancet 2014; 383 (9929): 1665-1676
  • Elder CJ, Somerset LM, Ram V, Wright NP, Wales JK, Dimitri PJ. Letter in response to Chitale et al: Determining the utility of the 60-minute cortisol measurement in the Short Synacthen Test. Clin Endo 2014; 80 (6): 925
  • Jackson C, Wernham EM, Elder CJ, Wright NP. Early glycaemic control is predictive of long-term control: A retrospective observational study. Practical Diabetes2013; 30(1): 16-18
  • Elder CJ, Sachdev P, Wright NP. The Short Synacthen Test: A questionnaire survey of current usage. Archives of Diseases in Childhood 2012; 97: 870-873.

ddd
Array
(
    [0] => Array
        (
            [message] => You currently have access to a subset of X API V2 endpoints and limited v1.1 endpoints (e.g. media post, oauth) only. If you need access to this endpoint, you may need a different access level. You can learn more here: https://developer.x.com/en/portal/product
            [code] => 453
        )

)

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close